2 Beaten-Down Stocks to Buy and Hold for 10 Years [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
It's harder to find beaten-down stocks that still look worth buying and holding onto for a while. Some corporations are condemned to deliver subpar financial results and stock market performances practically in perpetuity. Thankfully, Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) , two drugmakers that are failing to keep pace with broader equities, arguably don't belong to that group. Though these corporations have recently faced issues, there remain excellent reasons to invest in them for the long haul. Let's dig in deeper to see why. 1. Bristol Myers Squibb In the first quarter, Bristol Myers' revenue of $11.9 billion increased by 5% year over year. That's a decent, though not particularly impressive, performance for a pharmaceutical giant . However, it's worth pointing out that the company's year-over-year top-line growth was in the red for several quarters. Bristol Myers dealt with some important patent cliffs, but it seems to be turning the corner, partly thanks
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Nasopharyngeal Cancer Market to Reach USD 1,136.28 Million by 2033; Biomarker Discovery and Personalized Treatment to Propel Growth [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79% [Yahoo! Finance]Yahoo! Finance
- New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis [Yahoo! Finance]Yahoo! Finance
- Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion [Yahoo! Finance]Yahoo! Finance
- New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque PsoriasisBusiness Wire
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form 4
- 4/25/24 - Form 10-Q
- BMY's page on the SEC website